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Changes in Systolic Blood Pressure over Time in Healthy Cats and
Cats with Chronic Kidney Disease
E.S. Bijsmans, R.E. Jepson, Y.M. Chang, H.M. Syme, and J. Elliott
Background: Hypertension is a common problem in older cats, most often associated with chronic kidney disease (CKD).
Cross-sectional studies have suggested that blood pressure in cats increases with age.
Hypothesis/Objectives: To determine whether blood pressure in cats increases with age and whether this occurs indepen-
dently of the presence of CKD. To investigate risk factors for developing hypertension.
Animals/Subjects: Two hundred and sixty-five cats with CKD and 133 healthy cats ≥9 years were retrospectively identi-
fied.
Methods: Four groups were created according to status at initial evaluation (CKD or healthy) and blood pressure at the
last included visit (normotensive [NT] or developed hypertension [DH]): Healthy-NT, Healthy-DH, CKD-NT and CKD-DH.
Systolic blood pressure (SBP) over time slopes were compared with 0 and between groups. Risk factors for the development
of hypertension were investigated, and associations of biochemical and clinical variables with SBP were examined.
Results: Cats that were hypertensive at CKD diagnosis (n = 105) were not included in further analyses. Twenty-seven cats
with CKD and 9 healthy cats developed hypertension ≥3 months after diagnosis of CKD or their first visit. Systolic blood
pressure significantly increased with age in all cats (P < .001). Healthy cats were at less risk than cats with CKD to become
hypertensive (hazard ratio 0.2, P < .001), with creatinine being an independent risk factor for the development of hyperten-
sion.
Conclusions and Clinical Importance: The high prevalence of hypertension in azotemic cats in this study shows the impor-
tance of monitoring of SBP in elderly cats, and in particular in cats with CKD.
Key words: Feline; Hypertension; Renal disease; Risk factors.
Hypertension is a common problem in older catsbut, in contrast to humans, where 95–99% cases
of hypertension are considered to be primary or essen-
tial hypertension, hypertension in cats is most often
associated with underlying diseases such as chronic kid-
ney disease (CKD).1 Increased serum creatinine concen-
trations occur in up to 74% of hypertensive cats and
19–65% of cats with CKD are hypertensive.2–5 In
humans, the prevalence of CKD increases with increas-
ing age, and the same is true for cats.6,7 Mean values of
systolic blood pressure (SBP) also increase with age in
most human populations, as does the prevalence of clin-
ical hypertension.8,9 In cats, it has been suggested that
age is a predisposing factor for the development of
hypertension. A cross-sectional study grouping healthy
cats into 3 age groups (<5, 5–10 and older than
10 years) showed higher SBP in the older age groups,
although renal function was not assessed in all cats that
were classified as healthy.10 There is a positive correla-
tion between age and mean arterial pressure, but the
age distribution of the cats included in this study is not
known, which precludes interpretation of the results.11
Chronic kidney disease and hypertension are both
common in older cats and current consensus is that
hypertension is secondary to CKD, although the possi-
bility still exists that the hypertension occurs indepen-
dently of the presence of CKD or actually causes the
renal injury.12 The question can be raised whether this
increase in prevalence of hypertension and CKD in
older cats is purely age related, or whether the develop-
ment of hypertension in most cats is secondary to an
inability of the kidney to regulate blood pressure.12
Investigations into the risk factors for blood pressure to
increase in both healthy older cats and cats with CKD
may aid in answering this question. The hypothesis of
this study is that the blood pressure increases with age
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in senior cats and that the rate of this increase, and
therefore the occurrence of clinically significant hyper-
tension, is greater in cats with CKD.
Materials and Methods
Case Selection
Cats that were 9 years of age or older and examined for the
first time at 2 first opinion practices in central London (People’s
Dispensary for Sick Animals in Bow and Beaumont Sainsbury’s
Animal Hospital in Camden) between August 2000 and August
2012 were retrospectively identified. All cats had a follow-up per-
iod of ≥3 months and had visited 1 of the 2 veterinary practices a
minimum of 3 times. On every visit, a full history was obtained
and a physical examination was performed. Systolic blood pressure
was measured at all visits using a noninvasive Doppler techniquea
after a period of acclimatization and the SBP was calculated as
the average of 5 consecutive readings. Indirect fundoscopy after
applying 1 drop of tropicamide 1% to both eyes was performed at
the end of the consultation if average SBP was ≥160 mmHg. At
recruitment into the study, the owner consented to collection of
blood samples via jugular venipuncture and urine samples by cy-
stocentesis. Blood samples were collected into lithium heparin and
held on ice (4°C) for a maximum of 6 hours before centrifugationb
and separation. Plasma biochemistry was performed at an external
laboratoryc . Total thyroxine concentration was assessed in all cats
that showed clinical signs of hyperthyroidism (eg, polyphagia,
weight loss, tachycardia, and palpable goiter) or had plasma bio-
chemical findings that raised concern (increased alanine amino-
transferase or alkaline phosphatase activity). If the bladder was
palpable and a urine sample could be collected, a dipstick evalua-
tion was performed and a urine specific gravity (USG) was mea-
sured in all cats. In addition to this, the sediment of samples was
evaluated microscopically and, if bacteria or an active sediment
was found, urine was sent for bacterial culture and sensitivity test-
ing. All cats diagnosed with hyperthyroidism (total T4 > 55 nmol/
L) were excluded from the study, unless a thyroidectomy had been
performed ≥90 days before inclusion, to allow stabilization of glo-
merular filtration rate.13 Visits from cats that were being treated
with glucocorticoids, nonsteroidal anti-inflammatory drugs, antihy-
pertensive medications, erythropoietin, or intravenous fluid ther-
apy were excluded.
For the purposes of this study, systemic hypertension was diag-
nosed when cats had a SBP ≥170 mmHg on 2 consecutive visits
(reliably placing them in the category that is at moderate risk to
develop target organ damage)12 or SBP ≥160 mmHg with concur-
rent evidence of hypertensive retinopathy or choroidopathy on
indirect fundoscopy. All hypertensive cats were started on amlodi-
pine at a dose of 0.625 mg once daily at the time of diagnosis.
CKD was diagnosed in cats with renal azotemia (plasma creati-
nine concentration ≥2.0 mg/dL either on 2 consecutive visits or in
conjunction with USG <1.035). All owners of cats diagnosed with
CKD were advised to feed their cat a commercially available
renal diet. Cats were considered healthy if no significant clinical
signs were reported by the owner, no abnormalities were found
on clinical exam, and the blood results showed no evidence of
CKD or other pathologies. Cats were classified according to the
diagnosis of CKD and their SBP—the CKD-normotensive group
(CKD-NT-group) was composed of cats diagnosed with CKD
that did not meet the hypertensive criteria during follow-up, cats
in the CKD-developed-hypertension group (CKD-DH-group)
developed hypertension ≥3 months after diagnosis of CKD, cats
that met the criteria for being healthy were included in the
healthy-normotensive group (Healthy-NT-group), and cats were
included in the healthy-developed-hypertension group (Healthy-
DH-group) if the criteria for being healthy were met, but the cat
was diagnosed with idiopathic hypertension during follow-up of
≥3 months.
Re-examination of cats diagnosed with CKD was offered at a
maximum of 8 week intervals and blood- and urine samples were
obtained at a maximum of 16 week intervals. Re-examination of
healthy cats was offered at a maximum of 6 month intervals, at
which point blood- and urine samples were obtained. If a healthy
cat was diagnosed with CKD, its penultimate visit before develop-
ing azotemia was excluded from the analysis as it is likely that
nonazotemic CKD was already present at that stage.
Statistical Analyses
All statistical analyses were performed using commercially
available softwared. P-values ≤.05 were considered significant.
Descriptive statistics are presented to define the population, SBP,
biochemical and clinical variables at the first and last visit, and are
presented as median and interquartile range (IQR). Comparisons
between groups were performed using a nonparametric Kruskall-
Wallis or parametric ANOVA with post-hoc comparisons where
appropriate. Continuous variables were graphically assessed for
normality and values were log transformed if normality criteria
were not met to allow use in the linear mixed effects model and
the time-dependent Cox proportional hazards model.
Systolic blood pressure at the first visit between all 4 groups
was compared using a Kruskal–Wallis test with a Bonferroni
adjusted post-hoc comparison. The rates of change in SBP over
time and associations between SBP and biochemical (sodium,
chloride, phosphate, total calcium, potassium, creatinine, packed
cell volume (PCV), albumin, cholesterol) and clinical (weight,
heart rate) variables over time were compared between all groups
using a linear mixed effects model with subjects as random
effects, and time, group and sex as fixed effects. In the CKD-
DH-group and Healthy-DH-group, the actual SBP measurement
that resulted in the diagnosis of hypertension was not included in
the analysis. In the CKD-NT-group and Healthy-NT-group all
available visits were included. Not all cats had all information
available at all visits as, in general, blood samples were taken
every other visit, but having a SBP measurement was a require-
ment for the visit to be included in the models. Change in SBP
over time is expressed as ΔmmHg/100 days. A time-dependent
Cox proportional hazards model and Kaplan–Meier curves were
used to assess the association of the biochemical and clinical vari-
ables with the risk of becoming hypertensive. The assumption of
proportional hazards was checked for all variables included in
the model and cases were censored if they died, were lost to fol-
low-up (defined as not seen for >6 months and not contactable
by telephone), or if the study end point was reached. To investi-
gate the independent association of the significant variables with
SBP (linear mixed model) and the risk of becoming hypertensive
(time dependent Cox proportional hazards model), all significant
variables at the P < .10 level were included in a multivariable
analysis.
Results
A total of 265 cats were diagnosed with azotemic
CKD between August 2000 and August 2012 and were
seen for 3 or more visits, over the course of more than
3 months. Of these cats, 105 were hypertensive at diag-
nosis of CKD or were diagnosed with systemic hyper-
tension within 3 months of CKD diagnosis. These cats
were excluded from further analyses. Of the remaining
160 cats with CKD, 133 (83%) remained normotensive
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throughout follow-up (CKD-NT group), and 27 cats of
the 160 cats that were initially normotensive (17%)
developed hypertension ≥3 months after CKD diagnosis
(CKD-DH group). A total of 133 cats were included as
healthy cats in this study of which 9 (7%) developed
hypertension (Healthy-DH group), and 124 healthy cats
remained normotensive throughout follow-up (Healthy-
NT group).
Demographic Data
An overview of the clinical and biochemical variables
at baseline and at the last visit (NT-groups: last
included visit; DH-groups: hypertensive visit) is pre-
sented in Tables 1 and 2. The majority of cats included
in the 4 groups were domestic short hair (n = 229), fol-
lowed by domestic long hair (n = 34), and 147 cats were
female (of which 4 not neutered) and 146 cats male (of
which 4 not neutered). Of the 105 cats that were diag-
nosed as hypertensive at or within 3 months of CKD
diagnosis, 73 (70%) had visible retinal lesions, whereas
of the CKD-DH group 52% (14 cats) and of the
Healthy-DH group 3 cats (33%) had evidence of hyper-
tensive retinopathy.
Initial Visit
Chronic kidney disease-cats that remained normoten-
sive during follow-up had significantly lower mean
SBP at their first visit than CKD-cats that developed
hypertension, and Healthy-NT cats had a significantly
lower SBP than Healthy-DH cats (P < .05) (Table 1).
The SBP at baseline between the NT-groups did not
significantly differ, and neither did the DH-groups
(Table 1). Cats included in the Healthy-NT group were
significantly younger than both groups of cats with
CKD (P < .001) but the other groups did not signifi-
cantly differ in age (Table 1).
Rate of Change in Systolic Blood Pressure over Time
The CKD-DH, CKD-NT and Healthy-NT cats all
had a significant increase in SBP over time, although
the rates of change were not significantly different from
each other (P = .09; CKD-NT: 0.5  0.1, Healthy-NT:
0.4  0.1 mmHg, CKD-DH: 1.1  0.3, Healthy-DH:
0.3  0.5 mmHg/100 days). All rates of change, aside
from the Healthy-DH group, were significantly different
from 0 (P < .001).
Association Between Systolic Blood Pressure and
Biochemical Variables over Time
Using measurements from all time points available
for each cat, no significant association between creati-
nine, sodium, phosphate, total calcium, potassium, and
weight and SBP over time could be found. Cholesterol,
PCV, albumin and heart rate were significantly and pos-
itively associated with SBP and chloride was negatively
associated with SBP in the univariable analysis
(Table 3). In the multivariable model heart rate
(0.07  0.02 mmHg/bpm, P < .001) and PCV
(0.2  0.1 mmHg/L/L, P < .05) remained significantly
and positively associated with SBP.
Risk of Becoming Hypertensive
The Cox proportional hazards model showed that at
all time points, cats that were healthy were at less risk
than cats with CKD of becoming hypertensive (Hazard
ratio = 0.2 [95% confidence interval 0.08–0.36],
P < .001) (Fig 1). Sodium, chloride, total calcium,
potassium, cholesterol, PCV, albumin, weight and heart
rate were not significant risk factors for the develop-
ment of hypertension (Table 4). Increased phosphate
and creatinine concentrations were found to be
significant risk factors for the development of hyperten-
Table 1. Clinicopathologic variables for all groups at initial visit.
Variable
CKD-NT
(n = 133)
CKD-DH
(n = 27)
Healthy-NT
(n = 124)
Healthy-DH
(n = 9)
Age (years) 14 (12, 16)a 14 (13, 15)a 12 (10, 13)b 11 (10, 14)ab
Weight (kg) 3.9 (3.3, 4.7)a 3.7 (3.4, 4.7)ab 4.6 (3.6, 5.3)b 4.7 (3.9, 5.8)ab
SBP (mmHg) 133.2 (121.2, 144.6)a 147.2 (140.4, 156.1)b 131.6 (115.0, 143.7)c 145.6 (139.5, 154)ab
Heart rate (bpm) 186 (165, 204) 184 (164, 204) 180 (168, 197) 180 (176, 190)
PCV (%) 34 (32, 38)a 36 (31, 39)a 39 (36, 41)b 36 [34, 38)ab
Albumin (g/dL) 3.1 (3.0, 3.3)a 3.1 (2.9, 3.2)ab 3.2 (3.1, 3.4)b 3.3 (2.9, 3.5)ab
Creatinine (mg/dL) 2.4 (2.2, 2.9)a 2.5 (2.3, 2.8)a 1.5 (1.4, 1.7)b 1.5 (1.5, 1.6)b
Urea (mmol/L) 16.9 (14.4, 20.2)a 17.0 (13.6, 20.0)a 9.9 (8.9, 11.2)b 9.5 (8.4, 10.5)b
Phosphate (mg/dL) 4.22 (3.63, 5.12)a 3.97 (3.43, 4.73)ab 3.84 (3.3, 4.73)b 4.12 (3.47, 4.46)ab
Total calcium (mg/dL) 10.2 (9.9, 10.4)a 9.9 (9.7, 10.6)ab 9.8 (9.5, 10.3)b 10.1 (9.8, 10.6)ab
Sodium (mEq/L) 153.0 (151.3, 154.8)a 151.7 (150.5, 152.5)a 152.4 (151.3, 153.7)a 151.0 (150.0, 152.5)b
Potassium (mEq/L) 4.10 (3.80, 4.40) 4.10 (3.90, 4.38) 3.90 (3.70, 4.20) 3.80 (3.60, 4.25)
Chloride (mEq/L) 117.8 (116.3, 120.2)ab 116.0 (114.8, 118.9)a 119.3 (117.2, 120.6)b 120.4 (116.5, 121.2)ab
Cholesterol (mg/dL) 200 (154, 239) 201 (160, 234) 178 (151, 212) 166 (154, 205)
USG 1.020 (1.017, 1.024)a 1.017 (1.016, 1.022)a 1.050 (1.038, 1.060)b 1.042 (1.039, 1.050)b
CKD-DH, CKD-developed-hypertension; CKD-NT, CKD-remained normotensive; SBP, systolic blood pressure; PCV, packed cell vol-
ume; USG, urine specific gravity.
Parameters shown are at first visit for all cats. Superscript letters identify groups, which differed significantly.
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sion in the univariable analysis (P < .05). Creatinine
concentration was the only independent risk factor for
a cat becoming hypertensive (Hazard ratio = 7.3 [95%
confidence interval 1.2–45.4], P = .03).
Discussion
Of the initially normotensive cats with CKD, 17%
developed hypertension, whereas of the initially normo-
tensive healthy cats included in this study, 7% did. In
addition to this, 105/264 azotemic cats were hyperten-
sive at or within 3 months of CKD diagnosis. In cross-
sectional studies, 23% of hypertensive cats are nonazo-
temic and do not have an identifiable cause for their
hypertension,14 and 12% of nonazotemic, nonhyperthy-
roid cats are hypertensive at baseline.7 This study only
included healthy cats that developed hypertension at a
later time-point and excluded cats that were presented
as an idiopathic hypertensive cat at their first visit to
the clinic, which probably explains the lower prevalence.
The criteria for defining hypertension and the composi-
tion of the study population greatly influence reported
prevalence, and the prevalence of hypertension in cats
Table 2. Clinicopathologic variables for all groups at last visit.
Variable
CKD-NT
(n = 133)
CKD-DH
(n = 27)
Healthy-NT
(n = 124)
Healthy-DH
(n = 9)
Follow-up (days) 316 (225, 512) 379 (281, 771) 666 (495, 1065) 939 (685, 1217)
Age (years) 15 (13, 17)a 15 (14, 18)a 14 (12, 16)b 15 (14, 15)ab
Weight (kg) 3.6 (3.0, 4.5)a 3.7 (3.2, 4.3)ab 4.3 (3.4, 5.1)b 4.7 (3.4, 5.7)b
SBP (mmHg) 138.4 (120.5, 148)a 181.6 (175.0, 188.8)b 133.4 (121.1, 146.1)a 181.2 (174.8, 190)b
Heart rate (bpm) 186 (168, 210) 180 (160, 204) 184 (176, 204) 192 (186, 208)
PCV (%) 34 (30, 38)a 36 (29, 39)ab 37 (34, 40)b 37 (36, 40)ab
Albumin (g/dL) 3.1 (2.9, 3.3) 3.1 (2.9, 3.3) 3.1 (3.0, 3.4) 3.2 (3.1, 3.4)
Creatinine (mg/dL) 2.5 (2.1, 3.3)a 2.7 (2.4, 3.0)a 1.4 (1.3, 1.7)b 1.6 (1.4, 1.9)b
Urea (mmol/L) 16.9 [13.6, 22.0)a 17.1 (15.2, 21.1)a 10.5 (8.8, 12)b 10.9 (9, 11.8)b
Phosphate (mg/dL) 4.15 (3.55, 5.04)a 4.28 (3.72, 5.16)a 3.81 (3.50, 4.31)b 4.06 (3.53, 4.56)ab
Total calcium (mg/dL) 10.4 (10.0, 10.8)a 10.6 (10.1, 11.0)a 9.9 (9.5, 10.2)b 9.9 (9.8, 10.2)ab
Sodium (mEq/L) 154.3 (152.2, 156.4)a 153.8 (151.7, 154.9)ab 153.6 (152.0, 154.9)b 152.7 (151.0, 153.6)ab
Potassium (mEq/L) 4.20 (3.95, 4.50)a 4.10 (3.95, 4.55)ab 4.05 (3.80, 4.30)b 4.20 (3.79, 4.40)ab
Chloride (mEq/L) 119.1 (117.4, 120.8) 117.7 (115.8, 119.6) 118.9 (117.2, 120.8) 118.7 (117.3, 119.4)
Cholesterol (mg/dL) 200 (157, 247)a 212 (177, 256)ab 177 (147, 219)b 201 (151, 236)ab
USG 1.018 (1.016, 1.022)a 1.018 (1.015, 1.019)a 1.047 (1.032, 1.054)b 1.034 (1.034, 1.038)b
CKD-DH, CKD-developed-hypertension; CKD-NT, CKD-remained normotensive; SBP, systolic blood pressure; PCV, packed cell vol-
ume; USG, urine specific gravity.
Parameters shown are at last included visit for the-NT groups and first hypertensive visit for the-DH groups. Superscript letters identify
groups, which differed significantly.
Table 3. Linear mixed model investigating the associa-
tion between biochemical and clinical variables and sys-
tolic blood pressure over time.
Estimate  SE P-value
Creatinine (mg/dL) 3.0  2.2 .17
Sodium (mEq/L) 0.03  0.1 .75
Chloride (mEq/L) 0.2  0.08 .04
Phosphate (mg/dL) 0.4  0.4 .34
Total calcium (mg/dL) 0.6  0.6 .30
Potassium (mEq/L) 0.6  1.1 .56
Cholesterol (mg/dL) 0.02  0.009 .04
PCV (%) 0.30  0.10 .001
Albumin (g/dL) 4.5  1.8 .013
Weight (kg) 0.08  0.07 .27
Heart rate (bpm) 0.07  0.01 <.001
PCV, packed cell volume; SE, standard error.
Values depicted in bold were significantly associated with SBP
in the univariable analysis and were included in the multivariable
linear mixed model. PCV and heart rate remained significantly
associated with SBP.
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Fig 1. Kaplan–Meier curve of probability to become hyperten-
sive. CKD; chronic kidney disease, time is in days from first visit.
Cats with CKD have a greater probability to be hypertensive at
each time point than healthy cats (P < .001). Censored cases are
represented by ticks.
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with CKD in the current study is lower than the 65%
reported in a study performed in a referral setting,4 and
greater than the 19.4% previously reported in a cross-
sectional study using a higher SBP cut-off.3 In addition
to this, all cats included in this study had a minimum
follow-up of 3 visits over the course of 3 months. This
could have artificially increased the size of the group of
cats that were hypertensive at diagnosis of CKD, as
these cats came back for regular blood pressure checks
on antihypertensive medication.
Both healthy cats and cats with CKD included in this
study showed a significant increase in SBP with increas-
ing age. No significant increase in SBP over time could
be found for the healthy-DH group, although this was
most likely because of the small group size. The signifi-
cant increase in blood pressure with age is comparable
to the human situation.15 Studies investigating the age-
effect on blood pressure in cats are conflicting, but all
studies published to date commenting on this phenome-
non were cross-sectional in design.5,10,16–18 A moderate
correlation between all blood pressure variables and age
has been reported in cats,18 although a study including
only healthy cats did not find a significant correlation
between SBP and age.17 Sansom and co-workers
reported a higher blood pressure in older cats if the cats
were grouped according to age (younger than 5, 5–
10 years and older than 10). The cats that were
included in this study did, however, not all have serum
creatinine concentration measured, and the possibility
exists that cats with subclinical CKD have been
included, especially in the oldest age group.10 Another
study performed in a population of healthy cats, how-
ever, could not demonstrate a significant difference
between the SBP of cats <10 years of age and cats that
were 10 years or older.5 A further study including
healthy and ill cats did report an age cut-off, with cats
over the age of 11 years having significantly higher
blood pressure than cats younger than 11, although
renal function was not assessed in the apparently
healthy population of cats.18 Hypertensive cats have
been reported to be significantly older than their nor-
motensive counterparts, although the study population
consisted of a mixture of cats including cats with renal
disease and hyperthyroidism.16 Both diseases are associ-
ated with hypertension,12 and the prevalence of CKD
and hyperthyroidism also increases with age,6,7,19 which
means that the age effect found could be due to the
inclusion criteria of this study. To our knowledge, this
study is the first investigating changes in blood pres-
sures in individual healthy cats and cats with CKD over
time and is therefore the first to definitely show by lon-
gitudinal analysis that pressure rises with age in cats, as
it does in humans.
The positive association between heart rate and SBP
has commonly been reported in human literature. Mean
arterial pressure is determined by cardiac output and
peripheral resistance, and the association between heart
rate and SBP and can be attributed to the fact that car-
diac output is increased with an increased heart rate.20
A previous cross-sectional study found no significant
correlation between heart rate and SBP in healthy
cats.21 Heart rate has been reported to not be signifi-
cantly different in cats with higher blood pressures and
CKD when compared to healthy cats with lower blood
pressures,11 although a previous study reported 17% of
cats with hypertension to be tachycardic.14 To our
knowledge, this study is the first to investigate the asso-
ciation between heart rate and SBP over time in indi-
vidual cats. A positive independent association between
PCV and SBP was found in this study. Hematocrit is
the most important determinant of blood viscosity,
which in turn determines peripheral resistance together
with vascular diameter. Human studies have also
described this independent positive association between
PCV and SBP, and these studies also report an
increased PCV in hypertensive subjects compared to
normotensive subjects.22
Cats that develop hypertension have a higher baseline
blood pressure than their normotensive counterparts. In
the human literature the term ‘prehypertension’ is often
used to describe a nonoptimal baseline blood pressure.
Blood pressure and the incidence of hypertension
increases with age, and human subjects with higher
baseline blood pressure are at higher risk of becoming
hypertensive.23,24 The CKD-DH group had a signifi-
cantly higher blood pressure than both the CKD-NT
group and the healthy-NT group. The small size of the
healthy-DH group makes interpretation of the result
more challenging, although the SBP at time of inclusion
in the study seems comparable to the SBP of the CKD-
DH group. The World Health Organisation-Interna-
tional Society of Hypertension has guidelines to classify
nonhypertensive individuals into blood pressure catego-
ries (optimum, normal or high-normal). Based on these
categories, screening intervals are recommended for
human subjects, although these intervals differ between
organizations.24 No optimum recommendations exist
yet for screening intervals for individual elderly normo-
tensive cats, but based on the results obtained in this
study it could be argued that more frequent blood
Table 4. Cox proportional hazards model investigating
the risk factors for the development of hypertension.
HR 95% Confidence interval P-value
Creatinine (mg/dL) 9.39 2.06–42.82 .004
Sodium (mEq/L) 1.07 0.90–1.27 .47
Chloride (mEq/L) 1.00 0.92–1.08 .93
Phosphate (mg/dL) 1.34 1.03–1.74 .03
Total calcium (mg/dL) 0.88 0.51–1.53 .65
Potassium (mEq/L) 0.91 0.28–2.98 .87
Cholesterol (mg/dL) 1.00 1.00–1.01 .38
PCV (%) 0.95 0.86–1.05 .3
Albumin (g/dL) 0.72 0.17–3.11 .66
Weight (kg) 0.81 0.58–1.14 .22
Heart rate (bpm) 1.00 0.98–1.00 .16
PCV, packed cell volume.
Values depicted in bold were a significant risk factor for the
development of hypertension in the univariable analysis and
included in the multivariable Cox proportional hazards model.
Creatinine remained the only independent risk factor for the devel-
opment of hypertension.
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pressure measurements need to be encouraged if an
owner presents a cat with a mean SBP ≥140 mmHg. Cats
with CKD have a significantly greater probability of
becoming hypertensive, and creatinine is the only inde-
pendent predictor for becoming hypertensive, which
could call for an even shorter interval between screening
visits for cats with CKD. Of the cats that were diagnosed
as hypertensive, a greater percentage showed signs of tar-
get organ damage if they were diagnosed with CKD and
hypertension around the same time point (70%), when
compared with the cats that already came to the clinic for
regular blood pressure checks after their CKD diagnosis
(52%). The overall relatively high incidence of target
organ damage provides clinical validity to the diagnosis
of hypertension in most cats included in this study. A
shorter screening interval can aid in early diagnosis and
treatment of hypertension and therefore decrease the
development of target organ damage.
Having CKD increases the probability a cat develops
systemic hypertension, but their blood pressure does
not increase at a significantly greater rate than cats that
are healthy and become hypertensive, although this
result may have been affected by group size. Cats with
CKD included in this study were significantly older
than healthy cats that remained normotensive, and even
though the difference was not significant for the
healthy-DH group, the age of these cats seems compa-
rable to the healthy-NT group. This is a confounding
factor of this study, and difficult to control for as CKD
prevalence increases with age.6 There was no correlation
between creatinine concentration and SBP when the
data from all time points for each cat was used, similar
to the result of a cross-sectional study in cats with
CKD.5 A study investigating differences between hyper-
tensive and normotensive cats also reported no signifi-
cant difference in creatinine concentration between
groups.3
Human patients with end stage renal disease almost
invariably suffer from hypertension, but in human
CKD patients there is no correlation between serum
creatinine concentration and blood pressure,25,26
although a decline in creatinine clearance is mildly cor-
related with mean blood pressure in healthy subjects.15
It has been demonstrated that baseline creatinine is an
independent risk factor for the development of azotemic
CKD in cats.7 This study shows that creatinine is also
an independent risk factor for the development of
hypertension and that CKD cats are more likely to be
diagnosed with clinically significant hypertension. His-
torically it has been suggested that hypertension in most
cats is secondary to CKD, and several mechanisms,
such as activation of the renin-angiotensin-aldosterone
system (RAAS) and fluid retention have been
described.11,27,28 A recent study showed that plasma
renin activity is suppressed in hypertensive cats, whereas
plasma aldosterone concentration is increased, although
there was a substantial overlap among groups.28 How-
ever, it could be hypothesized that CKD and hyperten-
sion share a pathophysiological basis that is not yet
understood. The possibility exists that feline
hypertension has a genetic component, like essential
hypertension in humans,29 but to date no studies into
the genetics of feline hypertension have been published.
This is an area that warrants further investigation.
Conclusion
In conclusion, blood pressure increases with age in all
cats. Cats that develop clinically significant hyperten-
sion have a higher blood pressure at initial evaluation
than their normotensive counterparts and cats with
CKD are more likely to develop hypertension. The high
prevalence of hypertension in azotemic cats in this
study shows the importance of monitoring of SBP in
elderly cats and, in particular, in cats with CKD. It
could, therefore, be suggested that cats with a higher
baseline blood pressure at diagnosis of CKD should be
more closely monitored than cats with a lower baseline
blood pressure. Creatinine concentration is an indepen-
dent risk factor for the development of hypertension,
and early diagnosis of CKD is essential so that appro-
priate management can be offered.
Footnotes
a Parks Electronic Doppler Model 811B, Perimed UK, Bury St
Edmunds, UK
b Mistral 3000, Sanyo-Gallenkamp, Leicestershire, UK
c IDEXX Laboratories, Wetherby, Yorkshire, UK
d R i386 3.0.1; R Foundation for Statistical Computing, Vienna,
Austria and GraphPad Prism 6; GraphPad Software, La Jolla,
CA, USA.
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